Area of research
Pharmacology · Epidemiology
Research interest
Research interests include Antibiotics Pharmacokinetics and Efficacy, Pneumonia and Respiratory Infections, Hearing Loss and Rehabilitation, and Noise Effects and Management.
Pharmacokinetics and Safety of Ceftazidime-Avibactam in Neonates and Young Infants: A Phase 2a, Multicenter Prospective Trial.
Subtherapeutic Meropenem Antibiotic Exposure in Children With Septic Shock Assessed by Noncompartmental Pharmacokinetic Analysis in a Prospective Dataset.
Variability in Meropenem Distribution and Clearance in Children with Sepsis: Population-Based Pharmacokinetics with Assessment of Renal Biomarkers.
Clinical Practice Guideline by the Pediatric Infectious Diseases Society (PIDS) and the Infectious Diseases Society of America (IDSA): 2023 Guideline on Diagnosis and Management of Acute Bacterial Arthritis in Pediatrics
CDC Guidelines for the Prevention and Treatment of Anthrax, 2023
Bacteriophage Therapy of Multidrug-resistant Achromobacter in an 11-Year-old Boy With Cystic Fibrosis Assessed by Metagenome Analysis.
The Challenge of Extensively Drug-resistant Gram-negative Pathogens in Children: Newer Antibiotics and When to Use Them for Empiric and Definitive Therapy.
Antibiotics needed to treat multidrug-resistant infections in neonates
Clinical Features of Patients Hospitalized for All Routes of Anthrax, 1880–2018: A Systematic Review
Clinical Practice Guideline by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America: 2021 Guideline on Diagnosis and Management of Acute Hematogenous Osteomyelitis in Pediatrics
Use of Metagenomic Next-Generation Sequencing to Identify Pathogens in Pediatric Osteoarticular Infections
Harmonising regulatory approval for antibiotics in children
Therapeutic monitoring of vancomycin for serious methicillin-resistant <i>Staphylococcus aureus</i> infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists
Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists
Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin‐Resistant <i>Staphylococcus aureus</i> Infections: A Revised Consensus Guideline and Review of the American Society of Health‐System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists
Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists
Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa
Community-acquired pneumonia in children: cell-free plasma sequencing for diagnosis and management
Safety and Efficacy of Ceftazidime-Avibactam Plus Metronidazole in the Treatment of Children ≥3 Months to <18 Years With Complicated Intra-Abdominal Infection: Results From a Phase 2, Randomized, Controlled Trial
Invasive Pneumococcal Disease in Children’s Hospitals: 2014–2017
Polymyxin Susceptibility Testing and Interpretive Breakpoints: Recommendations from the United States Committee on Antimicrobial Susceptibility Testing (USCAST)
660: CELL-FREE NEXT-GENERATION SEQUENCING FOR DIAGNOSIS OF INFECTION IN HOSPITALIZED PEDIATRIC PATIENTS
Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa
Antiviral treatment of childhood influenza: an update
681: CELL-FREE PLASMA SEQUENCING FOR DIAGNOSIS AND MANAGEMENT OF PEDIATRIC COMMUNITY-ACQUIRED PNEUMONIA
Parents' perceived obstacles to pediatric clinical trial participation: Findings from the clinical trials transformation initiative
An Observational Study of Severe Pertussis in 100 Infants ≤120 Days of Age
Daptomycin for Complicated Skin Infections: A Randomized Trial
Intravenous Zanamivir in Hospitalized Patients With Influenza
Low Infection-Related Re-Admission Rates in a Retrospective of 4725 Children with Appendicitis Using a Clinical Pathway in a Tertiary Care Pediatric Center